Matthew Hawryluk - Feb 2, 2023 Form 4 Insider Report for Gritstone bio, Inc. (GRTS)

Role
Executive Vice President and Chief Business Officer
Signature
/s/ Vassiliki (Celia) Economides, Attorney-in-Fact for Matthew Hawryluk
Stock symbol
GRTS
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
4
Date filed
2/6/2023, 04:29 PM
Previous filing
Jan 4, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Award $0 +192K +339.18% $0.00 248K Feb 2, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") 137,291 of which vest semi-annually over four years and 54,480 of which vest annually over two years from February 1, 2023, in each case, subject to the Reporting Person's continuous service to the Issuer on each such date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2 Includes 3,189 shares of common stock purchased under the Issuer's Employee Stock Purchase Plan in transactions exempt from Section 16(b) pursuant to Rule 16b-3(c) and 191,771 RSUs which are subject to vesting.

Remarks:

Executive Vice President and Chief Business Officer